Evidence-Based Medicine Guidelines
Tamsulosin for benign prostatic hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamsulosin for Benign Prostatic Hyperplasia." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______.
Tamsulosin for benign prostatic hyperplasia. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______. Accessed November 4, 2025.
Tamsulosin for benign prostatic hyperplasia. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______
Tamsulosin for Benign Prostatic Hyperplasia [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 November 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamsulosin for benign prostatic hyperplasia
ID - 454992
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
